IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $697,809 | +92.5% | 72,462 | +112.7% | 0.01% | +60.0% |
| Q2 2023 | $362,452 | +59.7% | 34,065 | +72.9% | 0.01% | +25.0% |
| Q2 2022 | $227,000 | -93.3% | 19,707 | -92.7% | 0.00% | -90.2% |
| Q1 2022 | $3,378,000 | -26.9% | 268,526 | -32.3% | 0.04% | +24.2% |
| Q4 2021 | $4,622,000 | +601.4% | 396,405 | +685.1% | 0.03% | +450.0% |
| Q3 2021 | $659,000 | -19.1% | 50,493 | -20.2% | 0.01% | -14.3% |
| Q2 2021 | $815,000 | +71.2% | 63,277 | +51.3% | 0.01% | +75.0% |
| Q4 2020 | $476,000 | +280.8% | 41,815 | +200.4% | 0.00% | +100.0% |
| Q3 2020 | $125,000 | -15.0% | 13,921 | +26.1% | 0.00% | -33.3% |
| Q4 2019 | $147,000 | -6.4% | 11,044 | -4.8% | 0.00% | -50.0% |
| Q1 2019 | $157,000 | – | 11,603 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |